Compound Heterozygous Mutations of IL12RB1 in a Patient with Selective Defects in Th17 Differentiation

J Clin Immunol. 2020 May;40(4):647-652. doi: 10.1007/s10875-020-00771-0. Epub 2020 Mar 27.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / immunology*
  • Cell Differentiation
  • Cells, Cultured
  • Drug Resistance
  • Fatal Outcome
  • Female
  • Heterozygote
  • Humans
  • Immunologic Deficiency Syndromes / diagnosis*
  • Immunologic Deficiency Syndromes / genetics
  • Infant
  • Lymphocyte Activation
  • Mutation / genetics*
  • Nervous System Diseases / diagnosis*
  • Nervous System Diseases / genetics
  • Pedigree
  • Receptors, Interleukin-12 / genetics*
  • Sepsis / diagnosis*
  • Sepsis / genetics
  • Th17 Cells / immunology*

Substances

  • IL12RB1 protein, human
  • Receptors, Interleukin-12